Bind (Binding Authority)

In the context of insurance, a "bind" or "binding authority" refers to the process of placing coverage with an insurer. Specifically, it is the act of entering into a legally binding agreement with an insurer to provide coverage for a particular risk or set of risks.  

Some key features of a bind in insurance include:

  • Legal agreement: A bind is a legally binding agreement between an insurance agent or broker and an insurer to provide coverage for a particular risk or set of risks.

  • Coverage specifics: The bind includes specific details about the coverage being provided, such as the policy period, the types of coverage being provided, the limits of coverage, and the premium payment schedule.

  • Immediate coverage: Once the bind is in place, the policyholder typically has immediate coverage for the risks specified in the agreement, even if the policy itself has not yet been issued.

  • Binding authority: The authority to bind coverage is typically granted to insurance agents or brokers by the insurer. This allows them to enter into binding agreements on behalf of the insurer without prior approval for each individual policy.

For example, suppose a homeowner contacts an insurance agent to purchase a homeowner's insurance policy. The agent conducts a risk assessment and determines that the homeowner is eligible for coverage. The agent then enters into a bind with an insurer to provide coverage for the homeowner's property. The bind includes details such as the policy period, the types of coverage being provided (e.g. dwelling coverage, personal property coverage), the limits of coverage, and the premium payment schedule. Once the bind is in place, the homeowner has immediate coverage for the specified risks, even if the policy itself has not yet been issued. The insurer will then issue a policy to the homeowner that includes the terms of the bind, but the policyholder has coverage in the meantime.

Next Up

According to Mployer Insights’ 2026 analysis of 76,000+ employer benefit plans, disability insurance remains a major market differentiator, with only 41% of U.S. employers offering short-term disability (STD) and 38% offering long-term disability (LTD). While 60% salary replacement serves as the national standard across both benefit types, standard plan designs disproportionately expose higher earners due to median benefit caps of $1,602/week for STD and $8,273/month for LTD. Furthermore, alignment between STD benefit durations (median 26 weeks) and LTD elimination periods (68% at 90 days) remains a critical area for plan structure optimization.
Welcome to our latest release. We are excited for you to try the new features.
According to Mployer Insights’ 2026 analysis of 50,000+ employer health plans, prescription drugs account for over 25% of total benefit expenses, with Tier 4 specialty drugs driving the majority of high-cost claims. While Tier 4 copays average $123 with coinsurance requirements in 31% of plans, individual oncology therapies like Darzalex Faspro ($170,800/yr) and Keytruda ($158,200/yr) frequently exceed average individual stop-loss deductibles ($141,938). To mitigate exposure, self-funded employers are increasingly turning to independent, transparent PBM models and biosimilar substitution—which yields up to a 73% net cost reduction per patient.